Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)
This study tests whether a non-invasive brain stimulation technique called transcranial direct current stimulation (tDCS) can help reduce ADHD symptoms when used at home over four weeks. The researchers will also investigate whether using the device more frequently leads to better results and whether it can improve focus and decision-making abilities.
Key Objective: This trial is testing whether home-based tDCS can reduce ADHD symptoms and improve cognitive control and executive functioning.
Who to Consider: People with ADHD who are interested in exploring non-medication or complementary treatment options and are able to use a medical device at home should consider enrolling.
Trial Parameters
Brief Summary
The investigators are investigating whether home-based tDCS over the course of four weeks can improve ADHD symptom severity and improve dysexecutive functioning (cognitive control). Further, the investigators are investigating whether there is a dose-dependent response to tDCS.
Eligibility Criteria
Inclusion Criteria: 1. Male and female outpatients 18-65 years of age 2. A diagnosis of ADD/ADHD or meeting the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria. Exclusion Criteria: 1. Contraindication to tDCS: history or epilepsy, metallic implants in the head and neck, brain stimulators, vagus nerve stimulators, VP shunt, pacemakers, pregnancy. 2. Active substance dependence (except for tobacco). 3. Pregnant or nursing females. 4. Inability to participate in testing procedures. 5. Premorbid neurological conditions (including neurovascular and neurodegenerative diseases such as traumatic brain injury, stroke, Parkinson's, AD and other dementias) and severe psychiatric disorders (bipolar disorder, schizophrenia).